JP2003517476A5 - - Google Patents

Download PDF

Info

Publication number
JP2003517476A5
JP2003517476A5 JP2001543508A JP2001543508A JP2003517476A5 JP 2003517476 A5 JP2003517476 A5 JP 2003517476A5 JP 2001543508 A JP2001543508 A JP 2001543508A JP 2001543508 A JP2001543508 A JP 2001543508A JP 2003517476 A5 JP2003517476 A5 JP 2003517476A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
substituted alkyl
pharmaceutical composition
nhch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001543508A
Other languages
English (en)
Japanese (ja)
Other versions
JP5079961B2 (ja
JP2003517476A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/042313 external-priority patent/WO2001042207A2/en
Publication of JP2003517476A publication Critical patent/JP2003517476A/ja
Publication of JP2003517476A5 publication Critical patent/JP2003517476A5/ja
Application granted granted Critical
Publication of JP5079961B2 publication Critical patent/JP5079961B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001543508A 1999-11-29 2000-11-29 イレウスの治療及び予防のための新規な方法 Expired - Fee Related JP5079961B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45092099A 1999-11-29 1999-11-29
US09/450,920 1999-11-29
PCT/US2000/042313 WO2001042207A2 (en) 1999-11-29 2000-11-29 Novel methods for the treatment and prevention of ileus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012092605A Division JP5460771B2 (ja) 1999-11-29 2012-04-16 イレウスの治療及び予防のための新規な方法

Publications (3)

Publication Number Publication Date
JP2003517476A JP2003517476A (ja) 2003-05-27
JP2003517476A5 true JP2003517476A5 (cg-RX-API-DMAC7.html) 2008-01-31
JP5079961B2 JP5079961B2 (ja) 2012-11-21

Family

ID=23790061

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001543508A Expired - Fee Related JP5079961B2 (ja) 1999-11-29 2000-11-29 イレウスの治療及び予防のための新規な方法
JP2012092605A Expired - Fee Related JP5460771B2 (ja) 1999-11-29 2012-04-16 イレウスの治療及び予防のための新規な方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012092605A Expired - Fee Related JP5460771B2 (ja) 1999-11-29 2012-04-16 イレウスの治療及び予防のための新規な方法

Country Status (14)

Country Link
EP (1) EP1244448B1 (cg-RX-API-DMAC7.html)
JP (2) JP5079961B2 (cg-RX-API-DMAC7.html)
AT (1) ATE432076T1 (cg-RX-API-DMAC7.html)
AU (2) AU780738B2 (cg-RX-API-DMAC7.html)
CA (1) CA2393141C (cg-RX-API-DMAC7.html)
CY (1) CY1109264T1 (cg-RX-API-DMAC7.html)
DE (1) DE60042282D1 (cg-RX-API-DMAC7.html)
DK (1) DK1244448T3 (cg-RX-API-DMAC7.html)
ES (1) ES2329004T3 (cg-RX-API-DMAC7.html)
IL (2) IL149650A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02005336A (cg-RX-API-DMAC7.html)
NZ (1) NZ518684A (cg-RX-API-DMAC7.html)
PT (1) PT1244448E (cg-RX-API-DMAC7.html)
WO (1) WO2001042207A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274591B1 (en) 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
PL2368554T3 (pl) 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
MX2007010833A (es) 2005-03-07 2009-02-17 Univ Chicago Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
CN101426481B (zh) 2006-04-21 2012-12-05 帝斯曼知识产权资产管理有限公司 阿片受体拮抗剂的用途
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
JP5469593B2 (ja) 2007-03-29 2014-04-16 ワイス・エルエルシー 末梢性オピオイド受容体アンタゴニストおよびその使用
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
WO2008121348A2 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2719134C (en) 2008-03-21 2015-06-30 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
RU2455943C1 (ru) * 2011-02-01 2012-07-20 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Способ лечения обтурационной формы острой спаечной тонкокишечной непроходимости

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1420015B1 (de) * 1959-10-16 1971-08-26 Boehringer Sohn Ingelheim 2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
FR2514644A1 (fr) * 1981-10-19 1983-04-22 Sanofi Sa Composition pharmaceutique a action antagoniste peripherique des opiaces
WO1983003197A1 (en) * 1982-03-16 1983-09-29 Univ Rockefeller Method for controlling gastrointestinal dysmotility
US4806556A (en) * 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds

Similar Documents

Publication Publication Date Title
JP2003528819A5 (cg-RX-API-DMAC7.html)
US20200345718A1 (en) Morphinan Derivatives for the Treatment of Drug Overdose
JP2010511717A5 (cg-RX-API-DMAC7.html)
JP2003528819A (ja) オピオイドおよびそのアンタゴニストに関する新規方法および組成物
RU2009125597A (ru) Пролекарства и способы их получения и применения
CY1109264T1 (el) Νεες μεθοδοι για την θεραπεια και αποτροπη ειλεου
AR042463A1 (es) Tratamiento del dolor con combinaciones de nalbufina y agonistas del receptor de opioides kappa y antagosnistas del receptor opioides
AU2016244249B2 (en) Systems and methods for treating an opioid-induced adverse pharmacodynamic response
JPS61260025A (ja) オピオイド誘発の耐性および依存症における禁断症候群の抑制
RU2001132583A (ru) 3альфа-гидрокси-3бета-метоксиметил-21-гетероцикл-замещенные стероиды, фармацевтическая композиция, способ облегчения или профилактики бессонницы и способ погружения в наркоз субъекта-животного
WO2003051888A1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
WO2020055725A4 (en) Dopamine d3 receptor selective antagonists/partial agonists and uses thereof
CA2609733A1 (en) 6,7-unsaturated-7-carbamoyl-substituted morphinan derivative
JP2008501036A5 (cg-RX-API-DMAC7.html)
EP0514023B1 (en) Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal
JP7244992B2 (ja) オピオイドとn-アシルエタノールアミンの組み合わせ
ZA200510044B (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
CA2826154A1 (en) Peripherially acting .mu. opioid antagonists
JPWO2004007503A1 (ja) 悪心・嘔吐の治療または予防剤
US6828328B1 (en) Analgesic combination of muscarinic agonists
Inagaki et al. Naldemedine: peripherally acting opioid receptor antagonist for treating opioid-induced adverse effects
TH69989A (th) สารผสมตามสูตรตัวใหม่สำหรับการรักษาอาการเจ็บปวด โดยพึ่งพิงสารโอปิออยด์ ที่ประกอบรวมด้วย อนุพันธ์ 1,4-ได-พิเพอริดิน-4-อิล-พิเพอแรซีนที่ถูกแทนที่
HK1174496B (en) Morphinan derivatives for the treatment of drug overdose
HK40007565A (en) Methods for the synthesis of deuterated dextromethorphan